Cargando…

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models

In healthy individuals, immune control of persistent human cytomegalovirus (HCMV) infection is effectively mediated by virus-specific CD4(+) and CD8(+) T cells. However, identifying the repertoire of T cell specificities for HCMV is hampered by the immense protein coding capacity of this betaherpesv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lübke, Maren, Spalt, Stefanie, Kowalewski, Daniel J., Zimmermann, Cosima, Bauersfeld, Liane, Nelde, Annika, Bichmann, Leon, Marcu, Ana, Peper, Janet Kerstin, Kohlbacher, Oliver, Walz, Juliane S., Le-Trilling, Vu Thuy Khanh, Hengel, Hartmut, Rammensee, Hans-Georg, Stevanović, Stefan, Halenius, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062530/ https://www.ncbi.nlm.nih.gov/pubmed/31869419 http://dx.doi.org/10.1084/jem.20191164

Ejemplares similares

HLA-B locus products resist degradation by the human cytomegalovirus immunoevasin US11
por: Zimmermann, Cosima, et al.
Publicado: (2019)

Broad and Efficient Activation of Memory CD4(+) T Cells by Novel HAdV- and HCMV-Derived Peptide Pools
por: Höttler, Alexander, et al.
Publicado: (2021)

Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma
por: Bilich, Tatjana, et al.
Publicado: (2020)

The Peptide Vaccine of the Future
por: Nelde, Annika, et al.
Publicado: (2021)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Human cytomegalovirus antagonizes activation of Fcγ receptors by distinct and synergizing modes of IgG manipulation
por: Kolb, Philipp, et al.
Publicado: (2021)

Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
por: Falk, Jessica Julia, et al.
Publicado: (2018)

MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells
por: Nachmani, Daphna, et al.
Publicado: (2014)

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
por: Marcu, Ana, et al.
Publicado: (2021)

ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients
por: Zavaglio, Federica, et al.
Publicado: (2023)

Deletion of the non-adjacent genes UL148 and UL148D impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2023)

Human Cytomegalovirus (HCMV)-Specific CD4(+) and CD8(+) T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients
por: Gabanti, Elisa, et al.
Publicado: (2014)

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy
por: Nelde, Annika, et al.
Publicado: (2016)

Exploitation of Herpesviral Transactivation Allows Quantitative Reporter Gene-Based Assessment of Virus Entry and Neutralization
por: Reinhard, Henrike, et al.
Publicado: (2011)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT
por: Zaghi, Elisa, et al.
Publicado: (2021)

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
por: Wacker, Marcel, et al.
Publicado: (2023)

Human Cytomegalovirus and Autoimmune Disease
por: Halenius, Anne, et al.
Publicado: (2014)

Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA*008 to Escape Elimination by NK Cells
por: Seidel, Einat, et al.
Publicado: (2015)

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
por: Roerden, Malte, et al.
Publicado: (2020)

Improved Ribo-seq enables identification of cryptic translation events
por: Erhard, Florian, et al.
Publicado: (2018)

Identification of DNA-Damage DNA-Binding Protein 1 as a Conditional Essential Factor for Cytomegalovirus Replication in Interferon-γ-Stimulated Cells
por: Trilling, Mirko, et al.
Publicado: (2011)

HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
por: Tegeler, Christian M., et al.
Publicado: (2022)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini
por: Kowalewski, D J, et al.
Publicado: (2016)

Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?
por: Halenius, Anne, et al.
Publicado: (2015)

Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2017)

HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens
por: Backert, Linus, et al.
Publicado: (2017)

Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
por: Marconato, Maddalena, et al.
Publicado: (2022)

Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
por: Seller, Anna, et al.
Publicado: (2023)

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
por: Nelde, Annika, et al.
Publicado: (2021)

Persistent CD8 T Cell Marks Caused by the HCMV Infection in Seropositive Adults: Prevalence of HLA-E-Reactive CD8 T Cells
por: Rousselière, Amélie, et al.
Publicado: (2023)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
por: Bilich, Tatjana, et al.
Publicado: (2021)

Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
por: Becker, Tanja, et al.
Publicado: (2019)

Mouse Cytomegalovirus M34 Encodes a Non-essential, Nuclear, Early-Late Expressed Protein Required for Efficient Viral Replication
por: Eilbrecht, Mareike, et al.
Publicado: (2020)

Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)

A simple algorithm based on initial Ct values predicts the duration to SARS-CoV-2 negativity and allows more efficient test-to-release and return-to-work schedules
por: Anastasiou, Olympia E., et al.
Publicado: (2023)

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
por: Kubiniok, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u5n9dh5l2smbaenbumois9pk39